Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-03-22Clinical Trial Update: Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma [Phase 1, Phase 2]
The Phase 1/2 trial of reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
The trial evaluating Retacrit (epoetin zeta), a biosimilar, for chemotherapy-induced symptomatic anemia in hematology and oncology has compl…
-
CLINICAL_TRIALS research · 2017-03-10Clinical Trial Update: Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics [Phase 1]
Phase 1 clinical trial evaluating 18F-Al-NOTA-PRGD2 as a cancer imaging agent; the trial status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Multi-day Doses in Prevention of Nausea and Emesis [Phase 2]
Phase 2 trial evaluating multi-day dosing to prevent nausea and emesis in patients with multiple myeloma and lymphoma. The study completed a…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents [Phase 1]
A Phase 1 feasibility trial evaluating the ability to assess lymphoma response to precisely injected candidate chemotherapy agents has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-02-14Clinical Trial Update: Phase I Study of CS-7017 and Bexarotene [Phase 1]
Phase I trial of CS-7017 in combination with Bexarotene for solid tumors, lymphoma, and multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy [Phase 2]
Phase 2 trial evaluating epoetin alfa or darbepoetin alfa for chemotherapy-induced anemia; results from a completed study were posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: AMG 319 Lymphoid Malignancy FIH [Phase 1]
First-in-human Phase 1 clinical trial update for AMG 319 in lymphoid malignancies, including chronic lymphocytic leukemia and various lympho…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL) [Phase 1]
Phase 1 trial of LMP2a-specific cytotoxic T-lymphocytes for lymphoma has been terminated.
-
CLINICAL_TRIALS research · 2017-02-07Clinical Trial Update: EBUS-TBNA vs Flex 19G EBUS-TBNA [NA]
This is a clinical trial update comparing EBUS-TBNA needle options for sampling lymph nodes in patients with lymphadenopathy, lung cancer, s…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma [Phase 1]
Phase 1 study evaluating duvelisib in Japanese patients with relapsed or refractory lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome [NA]
This clinical trial update indicates the Lactobacillus probiotic study intended to prevent infection in patients undergoing donor stem cell …
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma [Phase 1]
Clinical trial update on VS-5584 describes a Phase I dose-escalation study in patients with advanced non-hematologic malignancies or lymphom…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: A Study of the HSP90 Inhibitor AUY922 [Phase 2]
The Phase 2 trial of the HSP90 inhibitor AUY922 (ganetespib) in lymphoma was terminated, with results posted in January 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating bendamustine hydrochloride for relapsed and primary refractory Hodgkin lymphoma has completed and posted r…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Testing a Personalize Medication Log for Patients With Lymphoma
Clinical trial update reporting completion of a study that tests a personalized medication log for patients with lymphoma.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine [EARLY_Phase 1]
Early-phase 1 trial update evaluating peripheral blood stem cell mobilization in relapsed lymphoma patients treated with bendamustine.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma [Phase 4]
Phase 4 trial investigating prophylactic Baraclude (Entecavir) to prevent hepatitis B reactivation in patients who are HBsAg negative/HBcAb …
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation [Phase 4]
Phase 4 clinical trial update evaluating erythropoietin for anemia after autologous hematopoietic stem cell transplantation in lymphoma pati…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies [Phase 1]
An open-label Phase 1/II clinical trial evaluating CPI-613 (devimistat) in patients with advanced malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 1]
Phase 1 study evaluating alemtuzumab with combination chemotherapy followed by donor lymphocyte infusion in patients undergoing donor stem c…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder [Phase 3]
Phase 3 trial evaluating cyclosporine eye drops to prevent eye graft-versus-host disease in patients after donor stem cell transplant for he…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer [Phase 3]
Phase 3 trial comparing nutritional supplements to prevent weight loss in cancer patients has completed.
-
CLINICAL_TRIALS withdrawal · 2016-12-05Clinical Trial Update: Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy [Phase 4]
Phase 4 clinical trial assessing changes in bone mineral density in lymphoma patients undergoing chemotherapy has been withdrawn. The study …
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma [Phase 1]
A Phase I study evaluating CUDC-427 for safety, tolerability and pharmacokinetics in patients with advanced and refractory solid tumors or l…